ETI-204, Anthim
Sponsors
Elusys Therapeutics
Conditions
AnthraxHealthy Volunteers
Phase 1
Intravenous Dose-Escalation Study With ETI-204 in Adult Volunteers
CompletedNCT00829582
Start: 2009-02-28End: 2009-09-30Target: 45Updated: 2017-11-14
Single Dose, Weight-Based, Dose-Escalation Study With Intravenous ETI-204 in Adult Volunteers
CompletedNCT01453907
Start: 2011-10-31End: 2012-12-31Updated: 2017-11-14